(1)
Xu, H.; Wang, D.; Ramponi, C.; Wang, X.; Zhang, H. The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease. IJDDP 2022, 1, 5.